Anxiety Outpatient -MindMed/WCT MM120-300

Jan 19

About the Study

This study is designed to evaluate the efficacy of a single dose of MM-120 (D-lysergic acid diethylamide D-tartrate), versus placebo, for the treatment of anxiety symptoms.

This study is sponsored by Mind Medicine, Inc.

Eligibility

You may be eligible to participate in this study if you:

are between the ages of 18-74 years old
are experiencing anxiety symptoms
have been diagnosed with Generalized Anxiety Disorder (GAD)
can spend the day at our facility for a 12-hour dosing session

If you are interested in participating in this clinical trial, please call our friendly staff at 801-871-5516 today. You can also fill out the contact form below.

Jamie Robison

Anxiety Outpatient -MindMed/WCT MM120-300

About the Study

Eligibility

Clinical trials advance medicine for the benefit of communities everywhere.
Inner Space Research provides patients access to emerging therapies and generates the rigorous data regulatory agencies need to evaluate their safety and efficacy.

Inner Space Research LLC

Anxiety Outpatient -MindMed/WCT MM120-300

About the Study

Eligibility

Depression Outpatient – Autobahn ABX-002-MDD-2001

Clinical trials advance medicine for the benefit of communities everywhere.Inner Space Research provides patients access to emerging therapies and generates the rigorous data regulatory agencies need to evaluate their safety and efficacy.

Inner Space Research LLC

Clinical trials advance medicine for the benefit of communities everywhere.
Inner Space Research provides patients access to emerging therapies and generates the rigorous data regulatory agencies need to evaluate their safety and efficacy.